seretide diskus 50mcg/250mcg inhalation powder, pre-dispensed
salmeterol xinafoate; fluticasone propionate - inhalation powder, pre-dispensed - 50mcg/250mcg - salmeterol xinafoate (8000001995) 50mcg; fluticasone propionate (8000031552) 250mcg - salmeterol and other anti-asthmatics
seretide diskus 50mcg/500mcg inhalation powder, pre-dispensed
glaxosmithkline trading services limited. (0000010863) 12 riverwalk, citywest business campus, dublin, dublin 24 - salmeterol xinafoate; fluticasone propionate - inhalation powder, pre-dispensed - 50mcg/500mcg - salmeterol xinafoate (8000001995) 72,5ug; fluticasone propionate (8000031552) 500ug - salmeterol and other anti-asthmatics
seretide diskus 50mcg/100mcg inhalation powder, pre-dispensed
glaxosmithkline trading services limited. (0000010863) 12 riverwalk, citywest business campus, dublin, dublin 24 - salmeterol xinafoate; fluticasone propionate - inhalation powder, pre-dispensed - 50mcg/100mcg - salmeterol xinafoate (8000001995) 72,5ug; fluticasone propionate (8000031552) 100ug - salmeterol and other anti-asthmatics
seretide diskus 50mcg/250mcg inhalation powder, pre-dispensed
glaxosmithkline trading services limited. (0000010863) 12 riverwalk, citywest business campus, dublin, dublin 24 - salmeterol xinafoate; fluticasone propionate - inhalation powder, pre-dispensed - 50mcg/250mcg - salmeterol xinafoate (8000001995) 72,5ug; fluticasone propionate (8000031552) 250ug - salmeterol and other anti-asthmatics
ciplacombo (25+250)mcg/dose εναιωρημα για εισπνοη υπο πιεση
cipla europe n.v., antwerp, belgium - salmeterol xinafoate, ΠΡΟΤΙΜΗΤΙΚΗ Φλουτουκασόνη - ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΕΙΣΠΝΟΗ ΥΠΟ ΠΙΕΣΗ - (25+250)mcg/dose - ineof00329 - salmeterol xinafoate - 25.000000 mcg; 0080474142 - fluticasone propionate - 125.000000 mcg - salmeterol and fluticasone
aerivio spiromax
teva b.v. - salmeterol xinafoate, το fluticasone propionate - pulmonary disease, chronic obstructive; asthma - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - Το aerivio spiromax ενδείκνυται για χρήση μόνο σε ενήλικες ηλικίας 18 ετών και άνω. asthmaaerivio spiromax ενδείκνυται για την τακτική θεραπεία των ασθενών με σοβαρό άσθμα, όπου η χρήση των προϊόντων συνδυασμού (εισπνεόμενου κορτικοστεροειδούς και μακράς δράσης β2 αγωνιστή) είναι κατάλληλη:ασθενείς που δεν ελέγχονται επαρκώς με μικρότερη δύναμη κορτικοστεροειδών συνδυασμό προϊόντων orpatients ήδη ελεγχόμενη υψηλή δόση εισπνεόμενων κορτικοστεροειδών και μακράς δράσης β2 αγωνιστή. Χρόνια Αποφρακτική πνευμονοπάθεια (ΧΑΠ)aerivio spiromax ενδείκνυται για τη συμπτωματική θεραπεία των ασθενών με ΧΑΠ με fev1.
seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - Ασθμα - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
bropair spiromax
teva b.v. - salmeterol xinafoate, το fluticasone propionate - Ασθμα - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
seretide 25mcg/50mcg inhaler
salmeterol; fluticasone propionate - inhaler - 25mcg/50mcg - salmeterol (89365-50-4) 25.000000000000ug; fluticasone propionate (8000031552) 50.000000000000ug - salmeterol and other anti-asthmatics
azelastine+fluticasone/win medica naspr.sus (137+50)mcg/actuation
azelastine hydrochloride; fluticasone propionate - naspr.sus (ΡΙΝΙΚΟ ΕΚΝΕΦΩΜΑ, ΕΝΑΙΩΡΗΜΑ) - (137+50)mcg/actuation - azelastine hydrochloride 137mcg; fluticasone propionate 50mcg - fluticasone, combinations